An2 Therapeutics, Inc. · NASDAQ:ANTX

BML Investment Partners, L.P. reported a 1.40% stake in An2 Therapeutics, Inc. (Schedule 13D/A)

Event Jun 17, 2025 · Filed Jun 18, 2025

BML Investment Partners, L.P. reported a 1.40% stake in An2 Therapeutics, Inc., 427,432 shares, with active intent on Jun 17, 2025. Filed Jun 18, 2025 (Schedule 13D/A).

Stake
1.40%
Shares
427,432
Intent
Active
What changed
Stake changed

The filing in full

HolderStakeShares
BML Investment Partners, L.P.1.40%427,432

Source

View original at SEC

Related